Tautomycetin
Tautomycetin is a polyketide natural product that is produced by certain strains of the bacteria Streptomyces. It is a potent protein phosphatase inhibitor, specifically targeting protein phosphatase 1 (PP1) and protein phosphatase 2A (PP2A). Tautomycetin has been studied for its potential use in cancer therapy due to its ability to inhibit cell growth and induce apoptosis in cancer cells.
Chemical Structure
Tautomycetin has a complex molecular structure that includes a 20-membered macrocyclic lactone ring, a dihydroxy-methyl-glutaric acid side chain, and a tetrahydrofuran ring. The macrocyclic lactone ring is highly oxygenated, with seven hydroxyl groups and two carbonyl groups. The dihydroxy-methyl-glutaric acid side chain is attached to the macrocyclic ring via an ester linkage.
Biosynthesis
The biosynthesis of tautomycetin involves a polyketide synthase (PKS) pathway. The PKS pathway is a complex series of enzyme-catalyzed reactions that assemble simple carbon units into a complex polyketide structure. The PKS pathway for tautomycetin involves the sequential addition of acetate and malonate units to a growing polyketide chain.
Biological Activity
Tautomycetin is a potent inhibitor of protein phosphatase 1 (PP1) and protein phosphatase 2A (PP2A), two important protein phosphatases involved in cell cycle regulation. By inhibiting these enzymes, tautomycetin disrupts the normal cell cycle and induces apoptosis in cancer cells. This makes tautomycetin a potential candidate for use in cancer therapy.
Potential Therapeutic Uses
Due to its potent inhibitory activity against PP1 and PP2A, tautomycetin has been studied for its potential use in cancer therapy. In preclinical studies, tautomycetin has been shown to inhibit the growth of various types of cancer cells, including breast cancer cells, prostate cancer cells, and leukemia cells. However, further research is needed to fully understand the potential therapeutic uses of tautomycetin.
See Also
This chemical compound related article is a stub. You can help WikiMD by expanding it.
Transform your life with W8MD's budget GLP-1 injections from $125.
W8MD offers a medical weight loss program to lose weight in Philadelphia. Our physician-supervised medical weight loss provides:
- Most insurances accepted or discounted self-pay rates. We will obtain insurance prior authorizations if needed.
- Generic GLP1 weight loss injections from $125 for the starting dose.
- Also offer prescription weight loss medications including Phentermine, Qsymia, Diethylpropion, Contrave etc.
NYC weight loss doctor appointments
Start your NYC weight loss journey today at our NYC medical weight loss and Philadelphia medical weight loss clinics.
- Call 718-946-5500 to lose weight in NYC or for medical weight loss in Philadelphia 215-676-2334.
- Tags:NYC medical weight loss, Philadelphia lose weight Zepbound NYC, Budget GLP1 weight loss injections, Wegovy Philadelphia, Wegovy NYC, Philadelphia medical weight loss, Brookly weight loss and Wegovy NYC
|
WikiMD's Wellness Encyclopedia |
| Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Contributors: Prab R. Tumpati, MD